Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/443661
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/443661
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

KLANE WHITE

Listed Specialty: Orthopaedic Surgery
4800 SAND POINT WAY NE, SEATTLE, WA, 98105-3901

2018 Payments: At a Glance

83

payments

$95,667

payment total

5

companies paid this doctor

Types of Payments

Category Payments Payment Value
Travel and Lodging
 34 $45,851
Promotional Speaking/Other
 8 $21,500
Consulting
 2 $14,106
Education
 18 $13,073
Food and Beverage
 21 $1,137

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
VIMIZIM

drug

 $37,773
BMN 165

drug

 $29,217
KUVAN

drug

 $29,217
NO PRODUCT DISCUSSED

drug

 $25,720
NAGLAZYME

drug

 $17,310
BMN 250

drug

 $13,073
BMN 111

drug

 $1,833
BRINEURA

drug

 $1,051
STRENSIQ

drug

 $82
Payments with no listed product

N/A

 $65
EXPEDIUM

device

 $53
VEPTR

device

 $12
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
May 19, 2018 $16,500 KUVAN BMN 165 Travel and Lodging BIOMARIN PHARMACEUTICAL INC.
Jun 22, 2018 $13,959 NO PRODUCT DISCUSSED Consulting GENZYME CORPORATION
Jun 22, 2018 $9,616 NO PRODUCT DISCUSSED Travel and Lodging GENZYME CORPORATION
May 20, 2018 $9,431 KUVAN BMN 165 Travel and Lodging BIOMARIN PHARMACEUTICAL INC.
May 20, 2018 $3,000 KUVAN BMN 165 Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Feb 23, 2018 $3,000 VIMIZIM NAGLAZYME Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
May 8, 2018 $3,000 VIMIZIM Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Sep 25, 2018 $2,655 VIMIZIM NAGLAZYME BMN 250 Education BIOMARIN PHARMACEUTICAL INC.
May 27, 2018 $2,655 VIMIZIM NAGLAZYME BMN 250 Education BIOMARIN PHARMACEUTICAL INC.
Sep 28, 2018 $2,500 VIMIZIM Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
May 2, 2018 $2,500 VIMIZIM Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
May 2, 2018 $2,500 VIMIZIM Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Aug 3, 2018 $2,500 VIMIZIM Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Sep 20, 2018 $2,500 VIMIZIM Promotional Speaking/Other BIOMARIN PHARMACEUTICAL INC.
Aug 3, 2018 $965 NO PRODUCT DISCUSSED Travel and Lodging GENZYME CORPORATION
Jun 1, 2018 $692 BMN 111 Travel and Lodging BIOMARIN PHARMACEUTICAL INC.
Sep 20, 2018 $677 VIMIZIM Travel and Lodging BIOMARIN PHARMACEUTICAL INC.
Apr 10, 2018 $641 VIMIZIM NAGLAZYME BMN 250 Education BIOMARIN PHARMACEUTICAL INC.
Aug 2, 2018 $641 VIMIZIM NAGLAZYME BMN 250 Education BIOMARIN PHARMACEUTICAL INC.
Mar 12, 2018 $641 VIMIZIM NAGLAZYME BMN 250 Education BIOMARIN PHARMACEUTICAL INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/443661

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.